Senate Resolution to Designate May 2026 as PSP and CBD Awareness Month
May 21, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The resolution serves as a formal federal recognition of two rare brain diseases, which may influence future research funding priorities and public health education efforts for the estimated 32,000 Americans currently diagnosed with these conditions.
Potentially affected actors named in the source documents. Mention is not a position.
Individuals diagnosed with PSP or CBD
The resolution recognizes their condition and supports efforts toward finding treatments and cures.
Family caregivers and loved ones
The resolution acknowledges the impact of these diseases on their lives and commends their efforts.
Healthcare professionals and researchers
The resolution commends their work and supports the goals of their research into these diseases.
Last recorded activity May 21, 2026.
Next step not available in the current record.
Summary
Key Facts
- The Senate supports designating May 2026 as 'Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month'.
- Approximately 30,000 Americans are estimated to be living with progressive supranuclear palsy (PSP).
- Approximately 2,000 Americans are estimated to be living with corticobasal degeneration (CBD).
- PSP and CBD are described as rare, adult-onset, rapidly progressing neurodegenerative disorders.
- Most individuals with these conditions become dependent on care within 3 to 4 years of symptom onset.
- The average life expectancy for those with these conditions is 7 to 8 years from symptom onset.
- There are currently no disease-modifying treatments available for PSP or CBD.
- The resolution supports increased research into diagnosis, prevention, treatments, and cures for both diseases.
- The resolution commends the caregivers, researchers, and healthcare professionals working with affected individuals.
Frequently Asked Questions
What are PSP and CBD?
Does this resolution provide funding for research?
Why It Matters
The resolution serves as a formal federal recognition of two rare brain diseases, which may influence future research funding priorities and public health education efforts for the estimated 32,000 Americans currently diagnosed with these conditions.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Rare Disease Awareness
The resolution highlights a specific legislative focus on rare, adult-onset neurodegenerative disorders that are frequently misdiagnosed.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance20How much this matters to a regular citizen
- Controversy0Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools